Carol Webb to Trans-Activators
This is a "connection" page, showing publications Carol Webb has written about Trans-Activators.
Connection Strength
1.661
-
Transgenic mice expressing dominant-negative bright exhibit defects in B1 B cells. J Immunol. 2008 Nov 15; 181(10):6913-22.
Score: 0.305
-
Anti-nuclear antibody production and autoimmunity in transgenic mice that overexpress the transcription factor Bright. J Immunol. 2007 Mar 01; 178(5):2996-3006.
Score: 0.271
-
Induction of immunoglobulin heavy-chain transcription through the transcription factor Bright requires TFII-I. Mol Cell Biol. 2006 Jun; 26(12):4758-68.
Score: 0.257
-
Bruton's tyrosine kinase regulates immunoglobulin promoter activation in association with the transcription factor Bright. Mol Cell Biol. 2005 Mar; 25(6):2073-84.
Score: 0.236
-
Mutations in the DNA-binding domain of the transcription factor Bright act as dominant negative proteins and interfere with immunoglobulin transactivation. J Biol Chem. 2004 Dec 10; 279(50):52465-72.
Score: 0.229
-
The transcription factor, Bright, is not expressed in all human B lymphocyte subpopulations. Cell Immunol. 2004 Mar; 228(1):42-53.
Score: 0.220
-
Signalling of the BCR is regulated by a lipid rafts-localised transcription factor, Bright. EMBO J. 2009 Mar 18; 28(6):711-24.
Score: 0.077
-
High frequency of matrix attachment regions and cut-like protein x/CCAAT-displacement protein and B cell regulator of IgH transcription binding sites flanking Ig V region genes. J Immunol. 2002 Sep 01; 169(5):2477-87.
Score: 0.050
-
Retinoids accelerate B lineage lymphoid differentiation. J Immunol. 2008 Jan 01; 180(1):138-45.
Score: 0.018